Abstract: Provided herein are pharmaceutically acceptable sodium thiosulfate and pharmaceutical compositions thereof. Also provided herein are methods for determining the total non-purgeable organic carbon in a sodium thiosulfate-containing sample. Further provided herein are methods for producing pharmaceutically acceptable sodium thiosulfate. Still further provided herein are methods of treatment comprising the administration of pharmaceutically acceptable sodium thiosulfate.

Abstract: Provided herein are pharmaceutically acceptable sodium nitrite and pharmaceutical compositions thereof. Also provided herein are methods for determining the total non-volatile organic carbon in a sodium nitrite-containing sample. Further provided herein are methods for producing pharmaceutically acceptable sodium nitrite. Still further provided herein are methods of treatment comprising the administration of pharmaceutically acceptable sodium nitrite.

Abstract: Provided herein are pharmaceutically acceptable sodium nitrite and pharmaceutical compositions thereof. Also provided herein are methods for determining the total non-volatile organic carbon in a sodium nitrite-containing sample. Further provided herein are methods for producing pharmaceutically acceptable sodium nitrite. Still further provided herein are methods of treatment comprising the administration of pharmaceutically acceptable sodium nitrite.

Abstract: Provided herein are pharmaceutically acceptable sodium nitrite and pharmaceutical compositions thereof. Also provided herein are methods for determining the total non-volatile organic carbon in a sodium nitrite-containing sample. Further provided herein are methods for producing pharmaceutically acceptable sodium nitrite. Still further provided herein are methods of treatment comprising the administration of pharmaceutically acceptable sodium nitrite.

Abstract: Provided herein are pharmaceutically acceptable sodium thiosulfate and pharmaceutical compositions thereof. Also provided herein are methods for determining the total non-purgeable organic carbon in a sodium thiosulfate-containing sample. Further provided herein are methods for producing pharmaceutically acceptable sodium thiosulfate. Still further provided herein are methods of treatment comprising the administration of pharmaceutically acceptable sodium thiosulfate.

Abstract: Provided herein are pharmaceutically acceptable sodium thiosulfate and pharmaceutical compositions thereof. Also provided herein are methods for determining the total non-purgeable organic carbon in a sodium thiosulfate-containing sample. Further provided herein are methods for producing pharmaceutically acceptable sodium thiosulfate. Still further provided herein are methods of treatment comprising the administration of pharmaceutically acceptable sodium thiosulfate.

Abstract: Provided herein are pharmaceutically acceptable sodium thiosulfate and pharmaceutical compositions thereof. Also provided herein are methods for determining the total non-purgeable organic carbon in a sodium thiosulfate-containing sample. Further provided herein are methods for producing pharmaceutically acceptable sodium thiosulfate. Still further provided herein are methods of treatment comprising the administration of pharmaceutically acceptable sodium thiosulfate.

Abstract: Provided herein are pharmaceutically acceptable sodium nitrite and pharmaceutical compositions thereof. Also provided herein are methods for determining the total non-volatile organic carbon in a sodium nitrite-containing sample. Further provided herein are methods for producing pharmaceutically acceptable sodium nitrite. Still further provided herein are methods of treatment comprising the administration of pharmaceutically acceptable sodium nitrite.

Abstract: Provided herein are pharmaceutically acceptable sodium thiosulfate and pharmaceutical compositions thereof. Also provided herein are methods for determining the total non-purgeable organic carbon in a sodium thiosulfate-containing sample. Further provided herein are methods for producing pharmaceutically acceptable sodium thiosulfate. Still further provided herein are methods of treatment comprising the administration of pharmaceutically acceptable sodium thiosulfate.

Abstract: Provided herein are pharmaceutically acceptable sodium nitrite and pharmaceutical compositions thereof. Also provided herein are methods for determining the total non-volatile organic carbon in a sodium nitrite-containing sample. Further provided herein are methods for producing pharmaceutically acceptable sodium nitrite. Still further provided herein are methods of treatment comprising the administration of pharmaceutically acceptable sodium nitrite.

Abstract: Provided herein are pharmaceutically acceptable sodium thiosulfate and pharmaceutical compositions thereof. Also provided herein are methods for determining the total non-purgable organic carbon in a sodium thiosulfate-containing sample. Further provided herein are methods for producing pharmaceutically acceptable sodium thiosulfate. Still further provided herein are methods of treatment comprising the administration of pharmaceutically acceptable sodium thiosulfate.

Abstract: Provided herein are pharmaceutically acceptable sodium thiosulfate and pharmaceutical compositions thereof. Also provided herein are methods for determining the total non-purgable organic carbon in a sodium thiosulfate-containing sample. Further provided herein are methods for producing pharmaceutically acceptable sodium thiosulfate. Still further provided herein are methods of treatment comprising the administration of pharmaceutically acceptable sodium thiosulfate.

Abstract: Provided herein are pharmaceutically acceptable sodium nitrite and pharmaceutical compositions thereof. Also provided herein are methods for determining the total non-volatile organic carbon in a sodium nitrite-containing sample. Further provided herein are methods for producing pharmaceutically acceptable sodium nitrite. Still further provided herein are methods of treatment comprising the administration of pharmaceutically acceptable sodium nitrite.

Abstract: The invention relates to a light source comprising: an at least partly light-transmitting elongate discharge vessel filled with an ionizable substance, at least one first electrode and at least one second electrode connected to respective end portions of the light source, between which first and second electrodes a discharge extends during lamp operation, at least one electrode of the first electrode and the second electrode extending laterally with respect to the corresponding end portion. The invention also relates to an assembly of light sources according to the invention.

Abstract: A mixture-lubricated internal combustion engine has a cylinder (2) in which a combustion chamber (3) is formed. The combustion chamber (3) is delimited by a piston (5) mounted to move back and forth. The piston (5) drives a crankshaft (7) rotatably journalled in a crankcase (4). The engine has an inlet channel (9) which supplies fuel and combustion air into the combustion chamber (3) as well as an exhaust outlet (13) from which exhaust gases flow from the combustion chamber. The intake inlet (11) and the exhaust outlet (13) are valve controlled. A flow connection is present between the crankcase (4) and the inlet channel (9). A good idle stability and a good idle acoustic of the engine are achieved in that at least one control valve (23, 33, 43, 63) is mounted in the flow connection.

Abstract: A mixture-lubricated internal combustion engine has a cylinder (2) in which a combustion chamber (3) is formed. The combustion chamber (3) is delimited by a piston (5) mounted to move back and forth. The piston (5) drives a crankshaft (7) rotatably journalled in a crankcase (4). The engine has an inlet channel (9) which supplies fuel and combustion air into the combustion chamber (3) as well as an exhaust outlet (13) from which exhaust gases flow from the combustion chamber. The intake inlet (11) and the exhaust outlet (13) are valve controlled. A flow connection is present between the crankcase (4) and the inlet channel (9). A good idle stability and a good idle acoustic of the engine are achieved in that at least one control valve (23, 33, 43, 63) is mounted in the flow connection.

Abstract: An exhaust muffler is provided for a motor in a hand held, portable implement such as a power chain saw, a disc grinder or cut-off machine, or the like, and includes a muffler housing that encloses at least one damping chamber. The housing has an inlet for exhaust gases from the motor, and an outlet. To improve the noise-absorbing or dampening properties of the muffler, it has a resonator chamber that is closed off so as to be substantially fluid-tight relative to the damping chamber. A resonance pipe that conveys exhaust gas is guided through the resonator chamber. An acoustic link is provided between the resonance pipe and the resonator chamber, and can be formed, for example, by openings or orifices in the resonance pipe.

Abstract: A method is described for detecting arthropod-borne human pathogens in arthropods using a rapid dipstick format where the signal for one or more pathogens can be visually detected on a single test dipstick. Specific examples of pathogens detected include Plasmodium species, togaviruses, flaviviruses, encephalitis viruses and Ross River virus. These tests are rapid, easy to use and are suited for use in the field.

Abstract: A foil blowing head for a thermoplastic synthetic resin tube has a primary air guide juxtaposed with the blowing head portion defining the internal primary air outlet, also formed with passages for the secondary air and is axially shiftable on the discharge tube from which air is led from the foil balloon.

Abstract: A plastic web is made by an extrusion apparatus having a plastics screw press, a metering pump with a volume flow depending on the rotation speed, an output die and a rolling unit with calendaring rolls. The flow of a thermoplastic material is regulated with the metering pump. The melt web issuing from the output die is cooled and calibrated. The process uses a metering pump which has substantially linear volume flow/rotation speed characteristics in the regulated range of rotation speeds and together with the rolling unit is part of a common computerized control system. The peripheral speed of the calendaring rolls is controlled so that it is proportional to the rotation speed of the metering pump. The special proportionality factor for the speed ratio is set by a computer which controls the roll speed so that no undesirable thickness variations or other product defects occur.